From the Journals

Model for Predicting Risk of Heart Failure or Cardiomyopathy After Breast Cancer Treatment

In a study reported in JAMA Oncology, Barac et al developed a risk prediction model for heart failure or cardiomyopathy after breast cancer treatment.

Share

8 Key Takeaways

  • 1

    Risk model aims to predict HF/CM in breast cancer patients.

  • 2

    Data analyzed from 26,044 patients.

  • 3

    Key predictors include age, treatment type, and health history.

  • 4

    Risks stratified into low, moderate, high categories.

  • 5

    High-risk patients had a 10-year HF/CM risk of 1

  • 6

    4%.

  • 7

    The model aids in tailored cardiac management.

  • 8

    Published in JAMA Oncology, study supported by NIH.

Original Source(s)

Model for Predicting Risk of Heart Failure or Cardiomyopathy After Breast Cancer Treatment

In a study reported in JAMA Oncology, Barac et al developed a risk prediction model for heart failure or cardiomyopathy after breast cancer treatment.

  • by Matthew Stenger

  • November 11, 2025

  • 3 min

Related Content

This Week’s Biopharma News: New Restrictions on Sarepta Gene Therapy

Our latest news roundup reports on the FDA’s new “plausible mechanism” pathway, Novartis’s phase III malaria trial, a new gene therapy in Europe, and more.

  • November 18, 2025

  • 5 min
The Analytical Scientist Innovation Awards 2025: #1

The technology ranked first in our 2025 Innovation Awards is… Countable PCR, from Countable Labs

Alcohol and Cancer Risk: Is a Drop Too Much?

In 2022, Congress requested a scientific review from the National Academies of Sciences, Engineering, and Medicine (NASEM) to study the associated risks of cancer and other health conditions and the u...